# Metabolic Syndrome & Insulin Resistance URL: https://genohealth.app/conditions/metabolic-syndrome Type: Condition Evidence: Strong evidence Last reviewed: 2025-06-30 ## Intro Metabolic syndrome is defined by having three or more of: central obesity, elevated fasting glucose, low HDL, high triglycerides, or elevated blood pressure. It's largely reversible with diet, exercise and weight loss — particularly when caught early. ## Summary A cluster of central adiposity, high blood pressure, dyslipidemia and high blood sugar that multiplies cardiovascular and type-2 diabetes risk. ## Key facts - Top biomarkers: Fasting insulin, A1c, triglycerides/HDL ratio - Key genes: TCF7L2, FTO, PPARG, MTNR1B - Highest-leverage lever: 5-10% body weight loss ## Diagnostic criteria (ATP III) - Waist circumference > 102 cm (men) or > 88 cm (women) - Fasting triglycerides ≥ 150 mg/dL - HDL < 40 mg/dL (men) or < 50 mg/dL (women) - Blood pressure ≥ 130/85 or on antihypertensive treatment - Fasting glucose ≥ 100 mg/dL or on glucose-lowering treatment ## Genetic context - TCF7L2 — strongest common genetic risk factor for type 2 diabetes - FTO — appetite regulation and body weight - PPARG — insulin sensitivity and fat storage - MTNR1B — fasting glucose regulation ## What works - 5-10% body weight loss reverses many components - Resistance training improves insulin sensitivity independent of weight - Lower-carb or Mediterranean patterns both work — adherence matters most - Walking after meals attenuates post-prandial glucose - Adequate sleep — one night of short sleep raises insulin resistance acutely ## Related (knowledge graph) ### Genes - TCF7L2 (/genes/tcf7l2): TCF7L2 is the strongest common genetic risk factor for type 2 diabetes within metabolic syndrome. [Strong evidence] - FTO (/genes/fto): FTO variants raise body-weight set point and the likelihood of meeting metabolic-syndrome criteria. [Moderate evidence] ## FAQ **Q: Can metabolic syndrome be reversed?** A: Yes, in most cases — particularly with 5-10% body weight loss, consistent exercise, and reducing ultra-processed food. Even when full reversal isn't possible, the components are individually treatable. **Q: Does TCF7L2 mean I'll get diabetes?** A: It raises risk but doesn't determine outcome. TCF7L2 carriers benefit especially from carbohydrate quality, weight management and exercise. ## Citations - Grant et al., Nat Genet 2006 (PMID 16415884): TCF7L2 variants substantially increase type 2 diabetes risk. Disclaimer: Informational only — not medical advice.